Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2012

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Rifaximin (Xifaxanta®) has been rejected for the treatment of travellers' diarrhoea that is not associated with fever, bloody diarrhoea, 8 or more unformed stools in the previous 24 hours or occult blood or leucocytes in the stool. The manufacturer failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2012' on Email Share 'SMC Update - August 2012' on Delicious Share 'SMC Update - August 2012' on Digg Share 'SMC Update - August 2012' on Facebook Share 'SMC Update - August 2012' on Google+ Share 'SMC Update - August 2012' on reddit Share 'SMC Update - August 2012' on StumbleUpon Share 'SMC Update - August 2012' on Twitter

atomic-wealth

No Comments to “SMC Update - August 2012”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,415 spam comments.

atomic-wealth
fond-illness
summer